Skip to content

A Randomized, Parallel-Controlled Clinical Study on the Treatment of Yin-Deficiency Type Cancer-Related Insomnia with Modified Baihe Dihuang Decoction Combined with Press Needle

A Randomized, Parallel-Controlled Clinical Study on the Treatment of Yin-Deficiency Type Cancer-Related Insomnia with Modified Baihe Dihuang Decoction Combined with Press Needle

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000859
Enrollment
Unknown
Registered
2026-04-02
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-Related Insomnia

Interventions

Traditional Chinese Medicine (TCM) Group:Taking sedative-hypnotic medication combined with the Modified Baihe Dihuang Decoction
Traditional Chinese Medicine Combined with Press Needle Group:Taking sedative-hypnotic medication combined with the Modified Baihe Dihuang Decoction and press needles
Control Group:The control group will continue the original anti-tumor treatment regimen and maintain the treatment (supportive and symptomatic treatment) as well as the sedative-hypnotic medications t

Sponsors

Yue Yang Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years and = 80 years; male or female. 2. Patients with a pathologically confirmed diagnosis of a malignant tumor. 3. Meet the diagnostic criteria for insomnia (or "bu mei" in TCM) according to both Western medicine and Traditional Chinese Medicine, and meet the diagnostic criteria for Yin-deficiency syndrome. 4. A cumulative score > 7 on the Pittsburgh Sleep Quality Index (PSQI). 5. Have been taking sedative-hypnotic medications (including benzodiazepines, non-benzodiazepines, antidepressants, or hormone replacement therapy) for at least one month prior to enrollment.

Exclusion criteria

Exclusion criteria: 1. Patients who are pregnant, lactating, or planning to become pregnant in the near future. 2. Patients with severe diseases of the heart, liver, kidneys, or hematopoietic system, or with a history of poorly controlled psychiatric disorders. 3. Patients with intracranial tumors, cognitive impairments, or those unable to cooperate with the investigation. 4. Patients currently participating in or having participated in another clinical drug trial within the past month. 5. Patients who had sleep disorders prior to their confirmed diagnosis of a malignant tumor. 6. Patients with a history of substance abuse or drug dependence. 7. Patients who have experienced severe psychological trauma recently, such as the death of a family member or close friend.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index;

Secondary

MeasureTime frame
EuroQol Five-Dimensional Five-Level;Hamilton Anxiety Scale;Hamilton Depression Scale;Insomnia Severity Index;Sleep apnea monitoring data / Data from sleep respiratory monitoring;

Countries

China

Contacts

Public ContactYabin Gong Chengxiu Zhong

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

gongyabin@hotmail.com+86 189 1892 3873

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026